In 2024, over 230,000 people are projected to be diagnosed with lung cancer, and more than 125,000 will lose their lives to the disease. With such high mortality rates, early detection through screenings is essential for improving treatment outcomes and survival. <a href='https://www.linkedin.com/feed/hashtag/?keywords=LungCancerAwareness&hig…; target='_blank'>#LungCancerAwareness</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LungCancerAwarenessMont…; target='_blank'>#LungCancerAwarenessMonth</a>
- Healthcare Professionals
- Therapies and Procedures
- Concomitant Surgical Ablation Therapy
- Ablation Sensing Unit & Switch Matrix
- cryoFORM® Cryoablation Probe
- cryoICE® BOX V6
- cryoICE® Cryoablation Probes
- Isolator® Linear Pen
- Isolator® Synergy™ Access® Clamp
- Isolator® Synergy™ Clamps (OLL2/OSL2)
- Isolator® Transpolar Pen (MAX3)
- Isolator® Synergy™ EnCompass® Clamp
- Multifunctional Ablation Generator (MAG)
- Hybrid AF™ Therapy
- Hybrid Total Thoracoscopic Therapy
- Left Atrial Appendage Management
- Cryo Nerve Block Therapy
- Concomitant Surgical Ablation Therapy
- Education & Training
- Clinical Evidence
- Product Labeling
- Resources
- Society Guidelines
- Therapies and Procedures
- Patients & Caregivers
- About AtriCure